How does a protein’s structure spell the difference between health and disease? Our journey to understand glaucoma-associated myocilin

6Citations
Citations of this article
9Readers
Mendeley users who have this article in their library.

Abstract

Over 20 years ago, alterations to the protein myocilin were confirmed to be linked to a heritable form of the prevalent eye disease, glaucoma, and 10 years ago, my lab set out to develop a deeper understanding of myocilin in its normal and diseased state. We have made strides in understanding how genetic mutations in myocilin likely lead to disease, but unlocking myocilin’s biological function is still an elusive goalpost. Is normal myocilin unimportant in the human body? Are scientists using the wrong methods to study myocilin biology? Here, I discuss my scientific journey into understanding one small part of the fascinating organ that is the eye.

Cite

CITATION STYLE

APA

Lieberman, R. L. (2019). How does a protein’s structure spell the difference between health and disease? Our journey to understand glaucoma-associated myocilin. PLoS Biology, 17(4). https://doi.org/10.1371/journal.pbio.3000237

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free